Benefit of 3-D Planning in Total Hip Replacement. A Prospective Randomized Study
1 other identifier
interventional
133
0 countries
N/A
Brief Summary
In this prospective randomized four-armed study the investigators aim to compare wheter 3-D planning, which necessitates preoperative CT acquisition and sophisticated planning together with engineers, results in measurable benefits in terms of objective and subjective outcome values in a collective of patients undergoing primary total hip replacement. Hypothesis:
- 1.When compared to 2-D planning, 3-D planning of a THR results in better hip reconstruction, better subjective and clinical outcome and better longevity of total hip implants.
- 2.When compared to a non-anatomical stem, an anatomical stem allows better hip reconstruction, better subjective and clinical outcome and better longevity of total hip implants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2012
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 6, 2021
CompletedFirst Posted
Study publicly available on registry
November 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 28, 2030
August 15, 2023
August 1, 2023
17.7 years
May 6, 2021
August 14, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of patients, including pain, stiffness, and physical functioning of the hip. A difference in WOMAC of 2.5 points is considered relevant. 3-D-planing and/or anatomical stems will be considered superior to 2-D-planing and /or non-anatomical stems if the one year WOMAC significantly differs by 2.5.
Change from basline to one year
Change in subjective hip value (SHV)
The subjective hip value (SHV) is as a patient-reported outcome measurement (PROM) which is reported by the patient. It is easily and quickly performed and interpreted. The SHV is defined as a patient's subjective hip satisfaction expressed as a percentage of 100%, which is the score that an entirely normal hip joint would reach. A difference in subj. hip value of 25% is considered relevant. 3-D-planing and/or anatomical stems will be considered superior to 2-D-planing and /or non-anatomical stems if the one year subjective hip value significantly differs by 25%.
Change from basline to one year
Study Arms (4)
3D anatomical stem
EXPERIMENTAL3-D-Planing with anatomical stem (SPS monoblock stem, Symbios)
3D non-anatomical stem
EXPERIMENTAL3-D-Planing with non anatomical stem (Quadra-H, Medacta)
2D anatomical stem
EXPERIMENTAL2-D-Planing with anatomical stem (SPS monoblock stem, Symbios)
2D non anatomical stem
EXPERIMENTAL2-D-Planning with non anatomical Stem (Quadra-H, Medacta)
Interventions
primary total-hip replacement (THR) planned on 3-dimensional images (computer tomography)
primary total-hip replacement (THR) planned on 2-dimensional images (anteroposteiros pelciv x-ray)
Eligibility Criteria
You may qualify if:
- patients aged 40-70 years scheduled for primary THR
- signed written informed consent.
You may not qualify if:
- Charnley class B and C
- ASA score \>2
- pregnancy
- gross hip deformity making complex hip reconstruction (greater trochanter advancement, acetabular augmentation, femoral osteotomy, use of cemented or revision stem) necessary
- immature patients and patients incompetent to judge
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Balgrist University Hospitallead
- Symbios Orthopedie SAcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2021
First Posted
November 15, 2021
Study Start
June 1, 2012
Primary Completion (Estimated)
January 28, 2030
Study Completion (Estimated)
January 28, 2030
Last Updated
August 15, 2023
Record last verified: 2023-08